(Q34459073)

2 August 2017

1 reference

title

Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease (English)

1 reference

2 August 2017

Franco RF

1

1 reference

PubMed ID

11736929

2 August 2017

Reitsma PH

series ordinal

2

1 reference

PubMed ID

11736929

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

British Journal of Haematology

2 August 2017

1 reference

2 August 2017

115

1 reference

2 August 2017

491-506

1 reference

2 August 2017

3

1 reference

Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Prothrombotic disorders in infants and children with cerebral thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Activated protein C resistance, factor V Leiden and peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Prevalence of the G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Coronary heart disease: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Thrombomodulin gene mutations associated with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Coagulation factor VII and the risk of coronary heart disease in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

21 January 2018

Atheroma: more than mush

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Ib alpha in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Genetic polymorphisms and risk of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Thrombi in acute coronary syndromes : revisited and revised

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Venous thrombosis: a multicausal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Glycoprotein IIIa polymorphism and risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Thrombophilia, polymorphisms, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The genesis of atherosclerosis and risk factors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Distribution and frequency of a polymorphic Alu insertion at the plasminogen activator locus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

The thrombomodulin gene mutation G(127)-->A (Ala25Thr) and cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Haemostatic factors and ischaemic heart disease. The Caerphilly study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Platelet GPIIb-IIIa blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03175.X

10.1046/J.1365-2141.2001.03175.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11736929